{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:52:20Z","timestamp":1789447940543,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.pmedr.2020.101184","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:52:57Z","timestamp":1598417577000},"page":"101184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Modeling dynamics of fatal opioid overdose by state and across time"],"prefix":"10.1016","volume":"20","author":[{"given":"R.","family":"Lyle Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janese","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-5358","authenticated-orcid":false,"given":"Ryan","family":"Edgerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8202-3040","authenticated-orcid":false,"given":"Julia","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"MacMaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhat","family":"Kalliny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0446-7671","authenticated-orcid":false,"given":"Miranda M.","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mathews-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-5264","authenticated-orcid":false,"given":"Mohammad","family":"Tabatabai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pmedr.2020.101184_b0005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1377\/hlthaff.2015.1673","article-title":"Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians","volume":"35","author":"Bao","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"Suppl. 1","key":"10.1016\/j.pmedr.2020.101184_b0010","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.drugalcdep.2016.08.641","article-title":"Targeting practitioners: a review of guidelines, training, and policy in pain management","volume":"173","author":"Barth","year":"2017","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.pmedr.2020.101184_b0015","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1377\/hlthaff.2015.1661","article-title":"Medical marijuana laws reduce prescription medication use in Medicare","volume":"35","author":"Bradford","year":"2016","journal-title":"Part D. Health Aff. (Millwood)"},{"issue":"2","key":"10.1016\/j.pmedr.2020.101184_b0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/003335491412900207","article-title":"Prescription drug monitoring and dispensing of prescription opioids","volume":"129","author":"Brady","year":"2014","journal-title":"Public Health Rep."},{"issue":"4","key":"10.1016\/j.pmedr.2020.101184_b0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/0033354918774330","article-title":"The effect of incomplete death certificates on estimates of unintentional opioid-related overdose deaths in the United States","volume":"133","author":"Buchanich","year":"2018","journal-title":"Public Health Rep."},{"key":"10.1016\/j.pmedr.2020.101184_b0030","unstructured":"Cartographic Boundary Shapefiles \u2013 States, 2017, United States Census Bureau, accessed 19 August 2018, https:\/\/www.census.gov\/geo\/maps-data\/data\/cbf\/cbf_state.html."},{"key":"10.1016\/j.pmedr.2020.101184_b0040","unstructured":"Centers for Disease Control and Prevention. 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes \u2014 United States. Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Published August 31, 2018. Accessed [date] from https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2018-cdc-drug-surveillance-report.pdf."},{"key":"10.1016\/j.pmedr.2020.101184_b0045","unstructured":"Centers for Disease Control and Prevention. Annual Surveillance Report of Drug-Related Risks\u2028and Outcomes \u2014 United States, 2017. Surveillance Special\u2028Report 1. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Published August 31, 2017. Accessed [date] from https:\/\/www.cdc.gov\/ drugoverdose\/pdf\/pubs\/2017-cdc-drug-surveillance-report.Pdf."},{"issue":"3","key":"10.1016\/j.pmedr.2020.101184_b0050","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MLR.0000000000001054","article-title":"Medicaid expansion and prescription trends: opioids, addiction therapies, and other drugs","volume":"57","author":"Cher","year":"2019","journal-title":"Med Care"},{"key":"10.1016\/j.pmedr.2020.101184_b0055","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMc1505541","article-title":"Shifting patterns of prescription opioid and heroin abuse in the United States","volume":"373","author":"Cicero","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pmedr.2020.101184_b0060","article-title":"Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: a national systematic legal review","author":"Davis","year":"2018","journal-title":"Elsevier."},{"key":"10.1016\/j.pmedr.2020.101184_b0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","article-title":"Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose","volume":"99","author":"Doe-Simkins","year":"2009","journal-title":"Am. J. Public Health"},{"issue":"15","key":"10.1016\/j.pmedr.2020.101184_b0070","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.pmedr.2020.101184_b0075","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2146\/ajhp100559","article-title":"Prescription drug take-back programs","volume":"68","author":"Fass","year":"2011","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.pmedr.2020.101184_b0080","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths \u2014 27 States, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"15","key":"10.1016\/j.pmedr.2020.101184_b0085","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archinternmed.2012.2374","article-title":"Prescription drug abuse and DEA-sanctioned drug take-back events: characteristics and outcomes in rural appalachia","volume":"172","author":"Gray","year":"2012","journal-title":"Arch. Int. Med."},{"issue":"1","key":"10.1016\/j.pmedr.2020.101184_b0090","article-title":"Association of pharmaceutical inductry marketing of opioid products with mortality from opioid related overdoses","volume":"2","author":"Hadlad","year":"2019","journal-title":"JAMA Netw Open."},{"issue":"6","key":"10.1016\/j.pmedr.2020.101184_b0095","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jamainternmed.2018.1999","article-title":"Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing","volume":"178","author":"Hadland","year":"2018","journal-title":"JAMA Int. Med."},{"issue":"6","key":"10.1016\/j.pmedr.2020.101184_b0100","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1377\/hlthaff.2017.1321","article-title":"Four states with robust prescription drug monitoring programs reduced opioid dosages","volume":"37","author":"Haffajee","year":"2018","journal-title":"Health Aff (Millwood)."},{"key":"10.1016\/j.pmedr.2020.101184_b0105","unstructured":"Hedegaard H, Warner M, Mini\u00f1o AM. Drug overdose deaths in the United States, 1999\u20132016. NCHS Data Brief, no 294. Hyattsville, MD: National Center for Health Statistics. 2017."},{"key":"10.1016\/j.pmedr.2020.101184_b0110","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011-2016. National Vital Statistics Reports. 2018; 67(9)."},{"key":"10.1016\/j.pmedr.2020.101184_b0115","doi-asserted-by":"crossref","unstructured":"Sordo Luis, Barrio Gregorio, Bravo Maria J, Indave B Iciar, Degenhardt Louisa, WiessingLucas et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesBMJ 2017; 357 :j1550 https:\/\/www.bmj.com\/content\/357\/bmj.j1550.long.","DOI":"10.1136\/bmj.j1550"},{"key":"10.1016\/j.pmedr.2020.101184_b0120","doi-asserted-by":"crossref","unstructured":"Mattick, RP; Breen, C; Kimber, J; Davoli, M; (2009) Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.Cochrane Database of Systematic Reviews (3). ISSN 1469-493X DOI: https:\/\/doi.org\/10.1002\/14651858.CD002209.pub2.","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"10.1016\/j.pmedr.2020.101184_b0125","doi-asserted-by":"crossref","first-page":"945","DOI":"10.15585\/mmwr.mm6734a2","article-title":"Opportunities to prevent overdose deaths involving prescription and illicit opioids, 11 States, July 2016\u2013June 2017","volume":"67","author":"Mattson","year":"2018","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.pmedr.2020.101184_b0130","unstructured":"Meit M, Heffernan M, Tanenbaum E. Final Report Appalachian Diseases of Despair. (2017), Appalachian Regional Commission."},{"issue":"10","key":"10.1016\/j.pmedr.2020.101184_b0135","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/add.13860","article-title":"Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States","volume":"112","author":"Moyo","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.pmedr.2020.101184_b0140","unstructured":"Multiple Cause of Death 1999\u20132017 on CDC Wide-ranging Online Data for Epidemiologic Research (CDC WONDER). Atlanta, GA: CDC, National Center for Health Statistics. 2018. Available at http:\/\/wonder.cdc.gov."},{"key":"10.1016\/j.pmedr.2020.101184_b0145","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse; Phillips JK, Ford MA, Bonnie RJ, editors. Washington (DC): National Academies Press (US); 2017 Jul 13."},{"key":"10.1016\/j.pmedr.2020.101184_b0150","unstructured":"National Alliance for Model State Drug Laws. Compilation of prescription monitoring program maps. http:\/\/www.namsdl.org\/library\/F2582E26-ECF8-E60A-."},{"key":"10.1016\/j.pmedr.2020.101184_b0155","unstructured":"National Conference of State Legislators. Prescribing Policies: States Confront Opioid Overdose Epidemic. NCSL website. http:\/\/www.ncsl.org\/research\/health\/prescribing-policies-states-confront-opioid-overdose-epidemic.aspx. Published October 31, 2018. Accessed January 10, 2019."},{"key":"10.1016\/j.pmedr.2020.101184_b0160","unstructured":"NIDA Opioid Summaries by state https:\/\/www.drugabuse.gov\/drugs-abuse\/opioids\/opioid-summaries-by-state."},{"key":"10.1016\/j.pmedr.2020.101184_b0165","unstructured":"NIDA. (2018). Nearly half of opioid-related overdose deaths involve fentanyl. Retrieved from https:\/\/www.drugabuse.gov\/news-events\/news-releases\/2018\/05\/nearly-half-opioid-related-overdose-deaths-involve-fentanyl on 2018, September 8."},{"issue":"2","key":"10.1016\/j.pmedr.2020.101184_b0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1137\/1025049","article-title":"The concept of elasticity in economics","volume":"25","author":"Nievergelt","year":"1983","journal-title":"SIAM Rev."},{"key":"10.1016\/j.pmedr.2020.101184_b0175","unstructured":"Office of National Drug Control Policy. Draft interim report. https:\/\/www.whitehouse.gov\/sites\/whitehouse.gov\/files\/ondcp\/commission-interim-report.pdf. Accessed December 27, 2018."},{"key":"10.1016\/j.pmedr.2020.101184_b0180","doi-asserted-by":"crossref","unstructured":"Powell D, Pacula RL, Jacobson M. Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? [Internet]. National Bureau of Economic Research; 2015. Report no.: 21345. Available at: http:\/\/www.nber.org\/papers\/w21345.","DOI":"10.3386\/w21345"},{"issue":"10","key":"10.1016\/j.pmedr.2020.101184_b0185","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","article-title":"Effect of Florida\u2019s prescription drug monitoring program and pill mill laws on opioid prescribing and use","volume":"175","author":"Rutkow","year":"2015","journal-title":"JAMA Int. Med."},{"key":"10.1016\/j.pmedr.2020.101184_b0190","first-page":"349","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants-United States, 2015\u20132016","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR"},{"key":"10.1016\/j.pmedr.2020.101184_b0195","doi-asserted-by":"crossref","unstructured":"Smart R. The Kids Aren\u2019t Alright but Older Adults Are Just Fine: Effects of Medical Marijuana Market Growth on Substance Use and Abuse [internet]. Rochester, NY: Social Science Research Network; 2015. Report no.: ID 2574915. Available at: http:\/\/papers.ssrn.com\/abstract=2574915.","DOI":"10.2139\/ssrn.2574915"},{"key":"10.1016\/j.pmedr.2020.101184_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/SAR.S47463","article-title":"Preventing deaths from rising opioid overdose in the US\u2014the promise of naloxone antidote in community-based naloxone take-home programs","volume":"4","author":"Straus","year":"2013","journal-title":"Subst Abuse Rehabil."},{"issue":"3","key":"10.1016\/j.pmedr.2020.101184_b0205","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.annemergmed.2017.10.023","article-title":"Effect of automated prescription drug monitoring program queries on emergency department opioid prescribing","volume":"71","author":"Sun","year":"2018","journal-title":"Ann. Emerg Med."},{"key":"10.1016\/j.pmedr.2020.101184_b0210","unstructured":"The Henry J. Kaiser Family Foundation. Opioid Overdose Deaths and Opioid Overdose Deaths as a Percent of All. January 31, 2018."},{"issue":"2","key":"10.1016\/j.pmedr.2020.101184_b0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am. J. Public Health"},{"issue":"4","key":"10.1016\/j.pmedr.2020.101184_b0220","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1377\/hlthaff.2016.1141","article-title":"States with prescription drug monitoring mandates saw a reduction In opioids prescribed to medicaid enrollees","volume":"36","author":"Wen","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.pmedr.2020.101184_b0225","doi-asserted-by":"crossref","unstructured":"Werle, Nick and Zedillo, Ernesto, We Can't Go Cold Turkey: Why Suppressing Drug Markets Endangers Society (March 28, 2018). Journal of Law, Medicine and Ethics, Forthcoming. Available at SSRN: https:\/\/ssrn.com\/abstract=3151622.","DOI":"10.1177\/1073110518782942"},{"issue":"2","key":"10.1016\/j.pmedr.2020.101184_b0230","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/1475-6773.12652","article-title":"Prescription drug monitoring programs produce a limited impact on painkiller prescribing in Medicare Part D","volume":"53","author":"Yarbrough","year":"2018","journal-title":"Health Serv. Res."}],"container-title":["Preventive Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335520301431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211335520301431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T15:02:23Z","timestamp":1761922943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211335520301431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":45,"alternative-id":["S2211335520301431"],"URL":"https:\/\/doi.org\/10.1016\/j.pmedr.2020.101184","relation":{},"ISSN":["2211-3355"],"issn-type":[{"value":"2211-3355","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling dynamics of fatal opioid overdose by state and across time","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmedr.2020.101184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101184"}}